Transcatheter or surgical treatment of aortic valve stenosis in patients with chronic kidney disease: an analysis from the randomized DEDICATE-DZHK 6 trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Mohamed Abdel-Wahab

Heart Center of Leipzig, Leipzig (Germany)

7 More presentations in this session

Presentation thumbnail

Effect of Aficamten on Cardiac Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The SEQUOIA-HCM CMR Trial

Doctor A. Masri (Portland, US)

Presentation thumbnail

Effect of Aficamten on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

Doctor J. Spertus (Kansas City, US)

Presentation thumbnail

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Doctor S. Hegde (Dallas, US)

Presentation thumbnail

Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial

Doctor A. Masri (Portland, US)

Presentation thumbnail

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis

Associate Professor M. Banovic (Belgrade, RS)

Access the full session

Session thumbnail

Trial updates and other studies in hypertrophic cardiomyopathy and aortic stenosis

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Session

Failing valves and beyond

Congress Presentation

Correlations with anatomic specimens

Congress Session

2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources